Welcome to our dedicated page for Zoetis SEC filings (Ticker: ZTS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Zoetis Inc. filings document the animal health company's operating results, capital returns, financing activity and governance disclosures. Recent 8-K reports furnish quarterly and annual financial results, guidance, dividend declarations, investor presentations and other Regulation FD disclosures.
The company's proxy materials address board and compensation matters, including executive pay and equity-award disclosures. Other filings record its New York Stock Exchange-listed common stock and debt financing, including a private offering of convertible senior notes, related indenture terms and capped call transactions.
Zoetis Inc. Executive Vice President Kevin Esch reported routine equity compensation activity. On April 30, 2026, he exercised restricted stock units to acquire 259 shares of Zoetis common stock at an exercise price of $0.00 per share. To cover tax obligations, 75 shares of common stock were disposed of at $114.97 per share as a tax-withholding transaction, not an open-market sale. Following these transactions, he directly holds 578 shares of common stock and indirectly holds 124.4082 common stock equivalents in the Zoetis Savings Plan, a 401(k) plan. He also continues to hold RSUs covering 44.1900, 205.8853 and 4043.3874 underlying shares of Zoetis common stock that will vest in stages on specified future anniversaries, subject to continued service.
Zoetis Inc ownership filing shows Vanguard Capital Management beneficially owned 30,277,753 shares of common stock, representing 7.17% of the class as reported with an as-of date of 03/31/2026. The filing states Vanguard exercises sole dispositive power over all 30,277,753 shares and sole voting power over 4,204,907 shares. The filing lists affiliated Vanguard entities that may exercise voting or dispositive power on certain holdings and is signed by Vanguard's Head of Global Fund Administration.
Zoetis Inc ownership update: Vanguard Portfolio Management reports beneficial ownership of 24,070,531 shares of Zoetis common stock, representing 5.7% of the class as of 03/31/2026. The filing states Vanguard exercises sole dispositive power over these shares and reports limited sole voting power of 103,131 shares. The filing notes these holdings include securities held for Vanguard funds and managed clients and identifies Vanguard Portfolio Management LLC and affiliated business divisions as the reporting entities.
FULLER JULIE reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Julie Fuller received a grant of 550.6435 phantom stock units on Zoetis common stock at a reference price of $39.64 per unit. Following this award, she holds a total of 1,798.0366 phantom stock units.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus a small amount of cash-equivalent investments, which typically account for around 5% of the unit’s total value. The units are settled in cash after her separation from service and may be transferred into an alternative investment fund, subject to Zoetis’ limits on the timing, frequency and permissibility of such transfers.
Lagano Roxanne reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Roxanne Lagano received a grant of 550.6436 phantom stock units under the Zoetis Supplemental Savings Plan. Each unit’s value is tied to Zoetis common stock plus a small cash-equivalent component, and the award is settled in cash after her separation from service.
The grant corresponds to 185.1986 shares of underlying Zoetis common stock for value-tracking purposes, and brings her total phantom stock unit balance to 30,632.2157 units. The units may be transferred into alternative investment funds, although Zoetis may limit the timing and frequency of such transfers.
Ferran Astorga Jeannette reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Ferran Astorga Jeannette received a grant of 4.997 phantom stock units on April 10, 2026. The award was made under the Zoetis Supplemental Savings Plan and increases the executive’s total phantom stock unit holdings to 2,250.8297 units.
These phantom stock units are cash-settled after the executive separates from service and may be reallocated among investment funds within plan limits. Each unit’s value is tied to the market value of Zoetis common stock plus a small cash-equivalent investment component that typically represents around 5% of the total value.
Zoetis Inc. Executive Vice President Kevin Esch reported a compensation-related grant of phantom stock units. On April 10, 2026, he acquired 1.3946 phantom stock units at a reference value of $39.64 per unit under the Zoetis Supplemental Savings Plan, bringing his total to 498.3855 phantom stock units.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, with the value determined by Zoetis’ market price and the cash-equivalent portion. These units are settled in cash after his separation from service and can be reallocated among plan investment funds, subject to Zoetis’ transfer limitations.
Zoetis Inc. reported that Chief Executive Officer Kristin C. Peck received a grant of 2,776.7700 phantom stock units on Zoetis common stock, valued at $39.6400 per unit. These units were acquired under the Zoetis Supplemental Savings Plan as a compensation-related award.
Each phantom stock unit represents a fraction of a phantom share of Zoetis common stock plus cash-equivalent investments, which typically make up around 5% of the unit’s value. The units are settled in cash after her separation from service, and their value is tied to Zoetis’s share price and the associated cash-equivalent investments.
Following this grant, Peck holds a total of 65,578.8067 phantom stock units directly under the plan. The filing does not reflect an open-market stock purchase or sale, but rather a non-market, cash-settled compensation award linked to Zoetis’s stock performance.
Driscoll Rimma reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. Executive Vice President Rimma Driscoll received a grant of 26.1975 phantom stock units on April 10, 2026 under the Zoetis Supplemental Savings Plan. This compensation award increases her total phantom stock unit balance to 6,035.7462 units, whose value is tied to Zoetis common stock plus a small cash-equivalent component.
Joseph Wetteny reported acquisition or exercise transactions in this Form 4 filing.
Zoetis Inc. reported that Chief Financial Officer Joseph Wetteny received a grant of 873.9476 phantom stock units on April 10, 2026 under the Zoetis Supplemental Savings Plan. Each unit’s value is tied to Zoetis common stock plus a small cash-equivalent component.
The units are cash-settled after his separation from service rather than delivering actual shares. Following this award, Wetteny holds a total of 9,792.3028 phantom stock units, notionally referencing 293.9359 shares of Zoetis common stock. This filing reflects routine compensation, not an open-market stock purchase or sale.